Page last updated: 2024-09-04

vx 497 and nelfinavir

vx 497 has been researched along with nelfinavir in 1 studies

Compound Research Comparison

Studies
(vx 497)
Trials
(vx 497)
Recent Studies (post-2010)
(vx 497)
Studies
(nelfinavir)
Trials
(nelfinavir)
Recent Studies (post-2010) (nelfinavir)
25371,240230240

Protein Interaction Comparison

ProteinTaxonomyvx 497 (IC50)nelfinavir (IC50)
Tyrosine-protein kinase FynHomo sapiens (human)7.971
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)8.852
ATP-dependent translocase ABCB1Homo sapiens (human)3.3938
Cytochrome P450 3A4Homo sapiens (human)1.275
ATP-dependent translocase ABCB1Mus musculus (house mouse)2.3
Sodium-dependent noradrenaline transporter Homo sapiens (human)8.852
Protease Human immunodeficiency virus 10.53
Protease Human immunodeficiency virus 10.0054

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Other Studies

1 other study(ies) available for vx 497 and nelfinavir

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023